Medacta : Mid Stabilisation Notice - Medacta Group SA
April 17, 2019 at 01:35 pm EDT
Share
DGAP-News: Credit Suisse Securities (Europe) Limited / Key word(s): Miscellaneous
Mid Stabilisation Notice - Medacta Group SA
17.04.2019 / 19:30
The issuer is solely responsible for the content of this announcement.
17/04/2019
Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.
Medacta Group SA
Mid-stabilisation Period Announcement
Credit Suisse Securities (Europe) Limited (contact: Lloyd Adams; +44 (0) 207 888 6341) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities within the limitations of Article 126 of the Swiss Ordinance on Financial Market Infrastructures and Market Conduct in Securities and Derivatives Trading (FMIO).
Securities
Issuer:
Medacta Group SA
Guarantor (if any):
N/A
Aggregate nominal amount:
855,000 Registered Shares
Description:
Registered Shares
Stabilisation Manager(s):
Credit Suisse Securities (Europe) Limited
(Acting on behalf of Credit Suisse AG)
Stabilisation transaction[s]
Date
Price Limit (CHF)
Units Bought
11/04/2019
96.00
50,000
11/04/2019
95.60
50,000
11/04/2019
95.45
50,000
12/04/2019
95.20
32,500
15/04/2019
95.15
15,500
16/04/2019
95.15
4,797
16/04/2019
95.27
10,000
17/04/2019
95.15
30,000
17/04/2019
95.00
30,000
17/04/2019
94.50
30,000
17/04/2019
94.00
30,000
17/04/2019
93.50
13,057
Stabilisation trading venue
SIX - SWISS EXCHANGE
This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.
This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
17.04.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
Medacta International SA is a Swiss-based company specialized in medical devices. The Company develops, manufactures and distributes orthopaedic and neurosurgical medical devices. The Company designs a number of products, such as hip products, including hip replacement, hip anatomy, hip diseases, and other products for the preparation of hip surgery; knee product, which encompasses knee anatomy, knee diseases, knee replacement, the stability of the knee and for the preparation of knee surgery; shoulder product, which includes shoulder anatomy, shoulder disease, shoulder replacement, and for the preparation of shoulder operation, and spine product, which includes products for spinal treatments, spinal anatomy and for surgery, among others. Additionally, the Company also offers training and support to healthcare professionals.
MEDACTA GROUP SA 
